Iohexol

Producers Shown on SFDA

Producer:Zhejiang Haizhou Pharmaceutical Co., Ltd. was established on August 11, 1997. Its business scope includes the manufacturing of APIs (see the Pharmaceutical Production License for details, and operate with valid licenses), the manufacturing of organic intermediates (only referring to 3-chloro-1,2-propanediol, trimethyliodosilane, trimethylbromosilane, tert butyl bromoacetate, tert butyl chloroacetate, hexamethyldisilane, 18% ammonia, and the annual by-products: hexamethyldisilane, 30% hydrochloric acid), toluene Recovery of ethanol, ethyl acetate, triethylamine, dichloromethane, cyclohexane, methanol, xylene, acetic acid and isopropanol (the above items shall be operated with valid licenses); Recycling and marketing of sodium chloride, manufacturing of organic intermediates (excluding hazardous chemicals and precursor chemicals), wholesale and retail of chemical raw materials (excluding hazardous chemicals and precursor chemicals, fireworks and crackers, drugs, and civil explosives), import and export of goods, and import and export of technology. (Projects that need to be approved according to law can only be operated after being approved by relevant departments.) Zhejiang Haizhou Pharmaceutical Co., Ltd. has invested in three companies and one branch.

Staff: 467 persons

Registered capital: 30.8 million

Producer: Zhejiang Stelli Pharmaceutical Co., Ltd. was established on September 15, 1997, and its business scope covers the manufacturing and sales of pharmaceutical intermediates; It is engaged in the export business of its own products and the import business of mechanical equipment, spare parts, raw and auxiliary materials needed by the enterprise, except for the commodities and technologies that are restricted or prohibited from import and export by the state. Manufacturing of bulk drugs (iohexol, iohexol, iodopanol, ioverol, levofloxacin hydrochloride, levofloxacin, pazufloxacin mesylate) (see Drug Production License for details); (Projects that need to be approved according to law can only be operated after being approved by relevant departments.) Zhejiang Stelli Pharmaceutical Co., Ltd. invested in 11 companies.

Staff: 881 persons

Registered capital: 343 million 20 thousand

For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978